Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON23109Recruiting
Randomised, double-blind trial of human insulin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Leiden University. Primary endpoints: Blood insulin during evocation day in patients and Blood glucose during evocation day in patients. Started May 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON23109.